Literature DB >> 1933805

Treatment of unknown primary melanoma.

A Velez1, D Walsh, C P Karakousis.   

Abstract

Sixty-four patients with unknown primary melanoma were identified among 1045 new patients with melanoma (6%) seen during an 11-year period. Their mean age was 44.5 years (median age, 42.7 years). Of these, 39 (59%) were men, and 25 (38%) were women. In 34, only one site was involved. Common single sites were the axilla (29%), groin (24%), and neck (32%). Most of the melanomas (88%) were melanotic. Patients with localized melanoma surgically treated (n = 34) had a median survival of 53 months, and a 5-year survival rate of 45%. The respective rates for disseminated melanoma were 7 months and 10% (P = 0.00001). Localized, unknown primary melanoma should be treated with radical excision because a substantial proportion of patients so treated survive 5 years.

Entities:  

Mesh:

Year:  1991        PMID: 1933805     DOI: 10.1002/1097-0142(19911215)68:12<2579::aid-cncr2820681209>3.0.co;2-g

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

1.  Melanin-targeted preclinical PET imaging of melanoma metastasis.

Authors:  Gang Ren; Zheng Miao; Hongguang Liu; Lei Jiang; Naengnoi Limpa-Amara; Ashfaq Mahmood; Sanjiv S Gambhir; Zhen Cheng
Journal:  J Nucl Med       Date:  2009-09-16       Impact factor: 10.057

2.  Metastatic Amelanotic Malignant Melanoma with Unknown Primary - A Case Report.

Authors:  Nikhil Moorchung; B Mukherjee; V Srinivas; H Subramanya
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Melanoma with unknown primary: report and analysis of 24 patients.

Authors:  Rita Clerico; Ugo Bottoni; Giovanni Paolino; Marina Ambrifi; Paola Corsetti; Valeria Devirgiliis; Stefano Calvieri
Journal:  Med Oncol       Date:  2012-03-30       Impact factor: 3.064

4.  Radiculopathy due to malignant melanoma in the sacrum with unknown primary site.

Authors:  Kenichiro Kakutani; Minoru Doita; Kotaro Nishida; Hiroshi Miyamoto; Masahiro Kurosaka
Journal:  Eur Spine J       Date:  2007-12-13       Impact factor: 3.134

5.  Improved survival for stage IV melanoma from an unknown primary site.

Authors:  Chris C Lee; Mark B Faries; Leslie A Wanek; Donald L Morton
Journal:  J Clin Oncol       Date:  2009-05-18       Impact factor: 44.544

6.  Treatment of Regional Metastatic Melanoma of Unknown Primary Origin.

Authors:  Elke J A H van Beek; Alfons J M Balm; Omgo E Nieweg; Olga Hamming-Vrieze; Peter J F M Lohuis; W Martin C Klop
Journal:  Cancers (Basel)       Date:  2015-08-10       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.